Clinical Trial Detail

NCT ID NCT02130869
Title A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

germ cell cancer

neuroblastoma

renal Wilms' tumor

brain cancer

Hodgkin's lymphoma

non-Hodgkin lymphoma

sarcoma

retinoblastoma

Therapies

Bendamustine + Cytarabine + Etoposide

Busulfan + Hu14.18K322A

Aldesleukin + Melphalan + Sargramostim

Filgrastim

Carboplatin + Etoposide

Age Groups: child

No variant requirements are available.